Pfizer requests to be delisted from the NYSE

[bambino]

Pfizer Buried Their Data in the Authorization Process—Fraud Becoming Clear—Could Lose Protections

Dr. Ryan Cole: "If an authorization from a legal point of view is obtained through fraud, then the liability protections these pharmaceutical companies are granted through the CARES Act by Common law, those protections go away."

@VigilantFox | Rumble Clip | Full Video


https://rumble.com/vx552v-pfizer-bur...g-clearco.html

[bambino]

Pfizer Knew Its mRNA “Vaccine” for Covid “Leaked Into Ovaries” but Covered It All Up


https://thetruthpatriots.com/pfizer-...red-it-all-up/

[the_real_Barleycorn]

Originally Posted by VitaMan

Your "sources" are all FAKE news generated by the radical right.

Notice how "right" became "radical right" under this bullshit?
Why would an organization that is known to be more moderate or right be disqualified from getting the news correct? Careful, or we will have to talk about the quality of journalism from "left leaning" sources and you don't want that.

So, why don't you challenge the story instead of the source...if you have contrary evidence?

[bambino]

Originally Posted by the_real_Barleycorn

Notice how "right" became "radical right" under this bullshit?
Why would an organization that is known to be more moderate or right be disqualified from getting the news correct? Careful, or we will have to talk about the quality of journalism from "left leaning" sources and you don't want that.

So, why don't you challenge the story instead of the source...if you have contrary evidence?

He never does. He’s just a garden variety troll.

[Yssup Rider]

Posted the contrary evidence in the first response to the OJO.

[bambino]

⚡️Pfizer has requested to be delisted from the New York Stock Exchange!

Coronavirus was officially declared a pandemic two years ago today (11 March 2020). Ironically today marks the day that Pfizer has been delisted from the New York Stock Exchange.

Pfizer filed a Form 25�� on 7 March, 2022 with the Securities and Exchange Commission (SEC). The form was a request to delist their securities from the New York Stock Exchange (NYSE) and to exit the public market. The Nasdaq delisting notice indicates that the company's last trading day was yesterday (10 March 2022).

A Pfizer spokesperson confirmed the news today, saying: "On March 7, 2022, the New York Stock Exchange (NYSE) filed a Form 25 (Notification of Removal from Listing and/or Registration under Section 12(b) of the Securities Exchange Act of 1934) related to the delisting of Pfizer’s 0.250% Notes due 2022.

"The 0.250% Notes due 2022 were euro-denominated notes that were paid in full on March 7, 2022 in accordance with their terms and maturity date. As a result, the 0.250% Notes due 2022 are no longer outstanding and thus are delisted from the NYSE. Pfizer’s Common Stock, $.05 par value (“PFE”) and Pfizer’s 1.000% Notes due 2027 (“PFE27”) continue to be listed on the New York Stock Exchange."

The Pfizer spokesperson provided no further commentary.

Court-mandated Pfizer documents unsealed

The news comes on the back of a stormy week in which court-mandated documents are being released by the FDA pertaining to its review of the clinical trials in support of Pfizer/BioNTech's Covid-19 vaccine license.

The court order will see 55,000 pages of Pfizer data released per month that was used to authorise their Covid-19 vaccine produced with BioNTech. BioNTech is a German biotechnology company based in Mainz with a branch in Cape Town, South Africa�� - that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases.

Both Pfizer (an American company) and BioNTech (a German company) were producing the Pfizer-BioNTech Cominarty Covid-19 vaccine. The documents under contention show 1291 listed adverse events linked to the Pfizer-BioNTech vaccine.

It is unclear whether the de-listed Pfizer will be acquired by BioNTech, and if so what formula will be used to fill the Covid-19 vaccines distributed by BioNTech going forward, and whether BioNTech will be supplying South Africans with Covid-19 vaccines.

###

https://t.me/georgenews | @GEORGENEWS

[VitaMan]

From your own referenced article. If you understood investing, maybe you would realize Pfizer continues to be listed on the NYSE.


Pfizer’s Common Stock, $.05 par value (“PFE”) and Pfizer’s 1.000% Notes due 2027 (“PFE27”) continue to be listed on the New York Stock Exchange."

[VitaMan]

Originally Posted by the_real_Barleycorn

Notice how "right" became "radical right" under this bullshit?
Why would an organization that is known to be more moderate or right be disqualified from getting the news correct? Careful, or we will have to talk about the quality of journalism from "left leaning" sources and you don't want that.

So, why don't you challenge the story instead of the source...if you have contrary evidence?

From the referenced article:




Pfizer’s Common Stock, $.05 par value (“PFE”) and Pfizer’s 1.000% Notes due 2027 (“PFE27”) continue to be listed on the New York Stock Exchange."

[VitaMan]

Originally Posted by dilbert firestorm

biontech purchased pfizer.


the delisting will take some time to go thru.

Looks to be more FAKE news, just like the headline of this thread.




Pfizer’s Common Stock, $.05 par value (“PFE”) and Pfizer’s 1.000% Notes due 2027 (“PFE27”) continue to be listed on the New York Stock Exchange."

[dilbert firestorm]

Originally Posted by VitaMan

Where did you read this ? It does not look correct.

that was an error. it appears that biontech is looking to acquire pfizer. its not certain tho. this was in the article.

[bambino]

https://www.bitchute.com/video/JrxpoAku5diu/

[dilbert firestorm]

Originally Posted by bambino

https://www.bitchute.com/video/JrxpoAku5diu/

this is weird. watch the CEO's neck.

[VitaMan]

Another bitchute item to toss in the trash

[bambino]

Originally Posted by VitaMan

Another bitchute item to toss in the trash

Then you threw Bourla’s own words in the trash. Sad.

[Why_Yes_I_Do]

Moderna Approves $900 Million+ Golden Parachute for CEO After Company Went From Losing $747 Million In 2020 to Making $12.2 Billion in 2021 With Its Covid Jab

Two things are certain with pandemics – one, some people are going to die; and two, some people are going to make a lot of cash.

Along with Pfizer-BioNTech, US-based vaccine manufacturer Moderna Inc. has been one of the largest beneficiaries of all following the release of the Fauci-funded Chinavirus from the Wuhan lab in early 2020. Over the past two years, the company has undergone an unthinkable turnaround from where it was before the pandemic hit, posting revenues of over $12,000,000,000 ($12B) in 2021 after losing a whopping $747 million in 2020.

What’s most astonishing about the change in fortune is that the entirety of Moderna’s income is attributable to the only commercially available product it offers: the experimental mRNA Covid-19 vaccine.

With sales from the vaccine expected to top last year’s numbers, the company has decided to reward its top executive, CEO Stephanie Bancel, with a massive ‘change-in-control’ package that will pay him upwards of $900 million dollars if the company is sold or merged and he loses his job in the process...